CN102872266B - 一种鹿胎复方药物制剂及其制备方法 - Google Patents
一种鹿胎复方药物制剂及其制备方法 Download PDFInfo
- Publication number
- CN102872266B CN102872266B CN201210379035.1A CN201210379035A CN102872266B CN 102872266 B CN102872266 B CN 102872266B CN 201210379035 A CN201210379035 A CN 201210379035A CN 102872266 B CN102872266 B CN 102872266B
- Authority
- CN
- China
- Prior art keywords
- cervi
- embryo cervi
- fetus
- fetus cervi
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title abstract description 14
- 210000003754 fetus Anatomy 0.000 title abstract 10
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 239000006228 supernatant Substances 0.000 claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000000725 suspension Substances 0.000 claims abstract description 12
- 239000004365 Protease Substances 0.000 claims abstract description 9
- 239000000084 colloidal system Substances 0.000 claims abstract description 8
- 239000008367 deionised water Substances 0.000 claims abstract description 8
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 8
- 108091005804 Peptidases Proteins 0.000 claims abstract description 6
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 6
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 3
- 210000001161 mammalian embryo Anatomy 0.000 claims description 48
- 238000009472 formulation Methods 0.000 claims description 14
- 235000010469 Glycine max Nutrition 0.000 claims description 10
- 244000068988 Glycine max Species 0.000 claims description 10
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims description 10
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 10
- 235000008696 isoflavones Nutrition 0.000 claims description 10
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- 238000002390 rotary evaporation Methods 0.000 claims description 6
- 238000005507 spraying Methods 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 108090000284 Pepsin A Proteins 0.000 claims description 4
- 102000057297 Pepsin A Human genes 0.000 claims description 4
- 229940088598 enzyme Drugs 0.000 claims description 4
- 229940111202 pepsin Drugs 0.000 claims description 4
- 235000019419 proteases Nutrition 0.000 claims description 4
- 108090000526 Papain Proteins 0.000 claims description 3
- 102000004142 Trypsin Human genes 0.000 claims description 3
- 108090000631 Trypsin Proteins 0.000 claims description 3
- 229940055729 papain Drugs 0.000 claims description 3
- 235000019834 papain Nutrition 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000012588 trypsin Substances 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 229960001322 trypsin Drugs 0.000 claims description 2
- 230000036039 immunity Effects 0.000 abstract description 8
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 2
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 2
- 235000003687 soy isoflavones Nutrition 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 238000001704 evaporation Methods 0.000 abstract 1
- 235000012907 honey Nutrition 0.000 abstract 1
- 239000013049 sediment Substances 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 12
- 239000013642 negative control Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 5
- 210000001541 thymus gland Anatomy 0.000 description 5
- 241000282994 Cervidae Species 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 238000002242 deionisation method Methods 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 4
- 238000007908 dry granulation Methods 0.000 description 4
- 210000003195 fascia Anatomy 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000011265 semifinished product Substances 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000007969 cellular immunity Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000145 Bacillolysin Proteins 0.000 description 1
- 101100129915 Escherichia coli (strain K12) melB gene Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
分组 | 剂量/体重(g/kg) | 胸腺/体重比值/(mg/g) | 脾脏/体重比值/(mg/g) |
空白对照组 | 0 | 1.69±0.87 | 5.02±0.73 |
阴性对照组 | 0.2 | 1.95±0.47 | 5.22±0.73 |
实施例1 | 0.2 | 2.56±0.75 | 5.73±0.46 |
实施例2 | 0.2 | 2.17±0.72 | 5.67±0.83 |
实施例3 | 0.2 | 2.53±0.69 | 5.62±0.59 |
实施例4 | 0.2 | 2.33±0.63 | 5.59±0.39 |
分组 | 平行1组 | 平行2组 | 平行3组 |
空白对照组 | 0.427±0.075 | 0.430±0.087 | 0.443±0.085 |
阴性对照组 | 0.509±0.053 | 0.504±0.062 | 0.497±0.035 |
实施例1 | 0.796±0.102 | 0.779±0.087 | 0.783±0.102 |
实施例2 | 0.776±0.087 | 0.775±0.056 | 0.780±0.068 |
实施例3 | 0.745±0.097 | 0.765±0.054 | 0.750±0.068 |
实施例4 | 0.749±0.098 | 0.746±0.065 | 0.756±0.046 |
分组 | 平行1组 | 平行2组 | 平行3组 |
空白对照组 | 45±0.065 | 43±0.047 | 43±0.085 |
阴性对照组 | 50±0.047 | 52±0.061 | 49±0.096 |
实施例1 | 81±0.102 | 79±0.087 | 82±0.082 |
实施例2 | 76±0.097 | 75±0.056 | 78±0.068 |
实施例3 | 79±0.042 | 79±0.107 | 80±0.086 |
实施例4 | 77±0.065 | 78±0.073 | 77±0.055 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210379035.1A CN102872266B (zh) | 2012-10-09 | 2012-10-09 | 一种鹿胎复方药物制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210379035.1A CN102872266B (zh) | 2012-10-09 | 2012-10-09 | 一种鹿胎复方药物制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102872266A CN102872266A (zh) | 2013-01-16 |
CN102872266B true CN102872266B (zh) | 2015-01-14 |
Family
ID=47473936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210379035.1A Active CN102872266B (zh) | 2012-10-09 | 2012-10-09 | 一种鹿胎复方药物制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102872266B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103239561A (zh) * | 2013-05-15 | 2013-08-14 | 吉林大学 | 家养梅花鹿鹿胎膏及其制备方法 |
CN110812310B (zh) * | 2019-11-14 | 2022-10-25 | 融致丰生制药有限公司 | 一种防脱发、滋养生发的鹿胎提取物、组合物及其制备方法与应用 |
CN114343175A (zh) * | 2021-12-29 | 2022-04-15 | 林杨 | 一种鹿胎膏即食粉 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1543987A (zh) * | 2003-11-18 | 2004-11-10 | 吉林大学 | 一种利用梅花鹿胎制备活性肽-鹿胎素的方法及应用 |
CN1857415A (zh) * | 2006-03-24 | 2006-11-08 | 张丽英 | 一种女性延缓衰老保健品及其制取工艺方法 |
CN101264159A (zh) * | 2007-03-15 | 2008-09-17 | 张洪义 | 鹿胎阿胶颗粒的加工方法 |
CN101874621A (zh) * | 2009-11-05 | 2010-11-03 | 蒋小明 | 一种鹿胎盘珍珠胶囊及其制备方法 |
CN102343022B (zh) * | 2011-03-07 | 2013-07-31 | 张朝峰 | 一种养颜鹿胎颗粒及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1799590A (zh) * | 2004-12-30 | 2006-07-12 | 魏自彬 | 鹿胎软胶囊及其制造方法 |
CN100402548C (zh) * | 2006-02-22 | 2008-07-16 | 郑彬 | 鹿胎盘生理活性多肽的制备方法 |
CN101953945A (zh) * | 2010-08-06 | 2011-01-26 | 四川金皇乐爽鹿业有限公司 | 鹿胎膏及其生产工艺 |
-
2012
- 2012-10-09 CN CN201210379035.1A patent/CN102872266B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1543987A (zh) * | 2003-11-18 | 2004-11-10 | 吉林大学 | 一种利用梅花鹿胎制备活性肽-鹿胎素的方法及应用 |
CN1857415A (zh) * | 2006-03-24 | 2006-11-08 | 张丽英 | 一种女性延缓衰老保健品及其制取工艺方法 |
CN101264159A (zh) * | 2007-03-15 | 2008-09-17 | 张洪义 | 鹿胎阿胶颗粒的加工方法 |
CN101874621A (zh) * | 2009-11-05 | 2010-11-03 | 蒋小明 | 一种鹿胎盘珍珠胶囊及其制备方法 |
CN102343022B (zh) * | 2011-03-07 | 2013-07-31 | 张朝峰 | 一种养颜鹿胎颗粒及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102872266A (zh) | 2013-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101455391B (zh) | 一种具有免疫调节功能的营养保健品及其制备方法 | |
CN102988827B (zh) | 一种铁皮石斛颗粒剂 | |
CN102988828A (zh) | 一种铁皮石斛颗粒剂的制备方法 | |
CN102872266B (zh) | 一种鹿胎复方药物制剂及其制备方法 | |
CN105132491A (zh) | 一种茯苓多糖的提取方法 | |
CN104585733A (zh) | 虫草口服片剂及其制备方法 | |
CN102114113B (zh) | 一种白头翁汤颗粒剂的制备方法 | |
CN1907258A (zh) | 一种面部清洁用品及其制备方法 | |
CN104605334A (zh) | 冬虫夏草口服片剂及其制备方法 | |
CN104705642A (zh) | 蛹虫草口服片剂及其制备方法 | |
CN101347396A (zh) | 含有植物提取物的洗面乳 | |
CN102813712A (zh) | 一种治疗鸡球虫的中药口服液 | |
CN102258447B (zh) | 爽身粉及其制备工艺 | |
CN101829246A (zh) | 提高免疫力的透皮输药贴制剂及其制备方法 | |
CN106901326A (zh) | 一种树舌灵芝全活性物质的制备与应用 | |
CN111195289A (zh) | 灵芝、灵芝孢子粉和女贞子的提取物胶囊及其制备方法 | |
CN102805836B (zh) | 一种治疗原发性肝癌的中药组合物及其制备方法 | |
CN103263491A (zh) | 中药组合物 | |
CN103202787A (zh) | 一种具有美白作用的护肤组合物及用途 | |
CN1240655A (zh) | 西红花养颜茶及其生产方法 | |
CN103859086A (zh) | 一种美容茶 | |
CN107115479A (zh) | 用于治疗急性湿热性皮肤病的中药组合物及其制备方法 | |
CN105012967A (zh) | 一种芩石利咽口服制剂的制备方法 | |
CN104784593A (zh) | 一种肉牛驱虫促生长制剂及其制备方法 | |
CN103584125A (zh) | 一种百合保健功能谷朊粉的加工方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191224 Address after: Room 501, 5th floor, 3rd floor, 188 West South Fourth Ring Road, Fengtai District, Beijing 100070 Patentee after: Beijing Zhongjing Fengchuang Technology Co., Ltd. Address before: 130011 No. 2699 Qianjin Street, Jilin, Changchun Patentee before: Jilin University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200123 Address after: 135099 north side of Jianguo Road, Meihekou City, Tonghua City, Jilin Province Patentee after: Hongben Shanyi Health Technology (Jilin) Co., Ltd Address before: Room 501, 5th floor, 3rd floor, 188 West South Fourth Ring Road, Fengtai District, Beijing 100070 Patentee before: Beijing Zhongjing Fengchuang Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200618 Address after: No.1, building B, labor Jiayuan, Meihekou City, Tonghua City, Jilin Province Patentee after: Baizhi Health Technology (China) Co., Ltd Address before: 135099 north side of Jianguo Road, Meihekou City, Tonghua City, Jilin Province Patentee before: Hongben Shanyi Health Technology (Jilin) Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211124 Address after: 135000 No. 3399, Nanhuan East Road, Meihekou City, Tonghua City, Jilin Province Patentee after: Naian Pharmaceutical (China) Co.,Ltd. Address before: 135099 No.1, building B, Laodong Jiayuan, Meihekou City, Tonghua City, Jilin Province Patentee before: Baizhi Health Technology (China) Co., Ltd |